Buy Like Buffett
Watchlist

Exascale Labs Holdings Inc.

XLAB · Technology · FY2026 filings · · Shallow moat ·

Doesn't clear the bar

Shallow moat
Share / Embed this score
Embed this score

The five investor questions

50

2025–2026 (latest 2 aligned FYs; v3 window cap 5): revenue $7M to $14.8M, increasing; diluted EPS -5106.44 to -8108.26, decreasing. Two-year history is scoreable but carries less confidence than a full-cycle record.

32

Median gross margin 16.0% over 2y, very stable.

—

Not enough years of ROIC data to score returns on capital.

55

Net cash position — no leverage risk.

44

Owner earnings changed trend unclear over up to the ten most recent annual observations, share count n/a.

The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.

Price vs. value if growth stopped today

A cautious baseline, not a price target: what the shares may support if normalized owner earnings simply hold steady.

Above value if growth stopped todayBelow value if growth stopped today
No price data
Not reported
Unavailable — insufficient owner-earnings data
Unavailable — insufficient growth-model data
$1.04
No price data

This zero-growth estimate assumes trailing owner earnings persist — unreliable for declining businesses. Flag status unavailable — four adjacent recent FY revenue observations are required.

Among the current top-score group, the median current price is 267% above the zero-growth estimate across 49 of the current top 50 companies by Moat Score with both values.

Score records captured Nov 12, 2026.

Exactly which 50 companies?

FTNT, IBEX, META, MEDP, MSFT, GOOG, LULU, ANF, IDXX, TXRH, FHI, QLYS, FFIV, ADBE, LLY, MANH, CPRT, VEEV, RMD, GRMN, PCTY, EAT, UI, SSD, MNST, DOCS, LRCX, MCO, NTAP, NVDA, CORT, SFM, MPTI, ULTA, SN, ROL, CTAS, PAYC, IRMD, DECK, MORN, INTU, JKHY, TPR, LGCY, UCFI, DAL, GWW, ISRG, MPWR

Missing a usable price or zero-growth estimate: ANF.

Model details under moat-index@3.0.0: zero-growth multiple 11.1×, capped-growth comparison at no more than 18×; 9% discount rate; high-end growth 0% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.

3 years of fundamentals

The business, in plain English

Exascale Labs Holdings Inc. booked $14.8M of revenue in FY2026 in the Technology sector and kept 16.3% of it as gross profit — a thin-margin business by that measure. After every other cost, −82.1% of each revenue dollar reached the bottom line.

XLAB's latest filed year, FY2026, doesn't disclose total debt in a form the methodology can use, so current leverage is treated as unmeasured — never assumed to be zero.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

FY2024–FY2026 · 3 fiscal years, normalized from XLAB’s SEC filings

Sales, as filed$14.8M FY2026
$0$10M202420252026
Revenue kept after cost of goods16.3% FY2026
0%10%202420252026
Standard ROIC or separately labeled Operating ROIC

Exact FY and FY-1 financing invested-capital inputs are required.

Exact FY and FY-1 financing invested-capital inputs are required.

Cash an owner could take out−$12.2M FY2026
−$10M−$5M$0202420252026

The explained ROIC gaps have filed inputs but no meaningful positive invested-capital denominator. Other gaps mean the item is not in the filings for that year. The series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Flagship explainer

How Exascale Labs Holdings Inc. makes its money

Exascale Labs Holdings Inc.'s filing does not supply enough comparable lines for a truthful flow chart — here's what is filed:

Table alternative
Filed lineValue% of revenueSource
$14.8M100%
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Cost of revenue$12.4M84%
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
$2.4M16%
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
−$4.8M−32%
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Income before tax−$12.2M−82%
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
−$12.2M−82%
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Source:
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
· event Jun 30, 2026 · retrieved Nov 12, 2026 · annual-row source set

Flagship explainer

What Exascale Labs Holdings Inc. owns — and owes

Exascale Labs Holdings Inc.'s filing tags don't support a full breakdown — here's what is filed:

Table alternative
Filed lineValue% of assetsSource
Total assets$6.7M100%
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Cash and equivalents$2.7M40%
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Stockholders’ equity−$25.2M−374%
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Source:
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
· event Jun 30, 2026 · retrieved Nov 12, 2026 · annual-row source set

Flagship explainer

What drives Exascale Labs Holdings Inc.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity64%Tax burden100%net income ÷ pretax incomeInterest burden253%pretax ÷ operating incomeOperating margin−32%operating income ÷ revenueAsset turnover2.11×revenue ÷ average assetsEquity multiplier-0.37×average assets ÷ average equityAs of 2026-06-30 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
−$12.2MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Income before tax−$12.2MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Operating income−$4.8MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
$14.8MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Ending assets$6.7MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Beginning assets$7.3MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
−$25.2MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
−$13MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Source: · event Jun 30, 2026 · retrieved Nov 12, 2026 · annual-row source set
Embed this chart

Flagship explainer

Where Exascale Labs Holdings Inc.'s cash went

Exascale Labs Holdings Inc.’s filing does not supply enough provenance-matched cash-flow lines for a truthful flow chart — here’s what is filed:

Table alternative
Filed lineValue% of cash from operationsSource
Cash from operations−$2.8M−100%
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Depreciation and amortization$67600%
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
Source:
  • 10-K · FY 2026Filing detailsAccession 0001829126-26-010462 · filed Sep 28, 2026
· event Jun 30, 2026 · retrieved Nov 12, 2026 · annual-row source set

Curated 19-manager tier

Who reported holding Exascale Labs Holdings Inc.

Delayed public 13F reports for 2026-Q2—not live positions, trades, or recommendations.

0 holding0 exited0 not holding0/19 resolved19 not retrieved

Named manager positions and quarter-over-quarter changes
ManagerReported positionQuarter-over-quarterFiling accession
Abrams CapitalNot retrievedComparison not retrievedFiling not retrieved
Akre CapitalNot retrievedComparison not retrievedFiling not retrieved
Baupost GroupNot retrievedComparison not retrievedFiling not retrieved
Berkshire HathawayNot retrievedComparison not retrievedFiling not retrieved
Brave Warrior AdvisorsNot retrievedComparison not retrievedFiling not retrieved
Dodge & CoxNot retrievedComparison not retrievedFiling not retrieved
First EagleNot retrievedComparison not retrievedFiling not retrieved
FundsmithNot retrievedComparison not retrievedFiling not retrieved
Gardner Russo & QuinnNot retrievedComparison not retrievedFiling not retrieved
Gates Foundation TrustNot retrievedComparison not retrievedFiling not retrieved
Mairs & PowerNot retrievedComparison not retrievedFiling not retrieved
Markel / Markel-GaynerNot retrievedComparison not retrievedFiling not retrieved
Oakmark / Harris AssociatesNot retrievedComparison not retrievedFiling not retrieved
Pershing SquareNot retrievedComparison not retrievedFiling not retrieved
Polen CapitalNot retrievedComparison not retrievedFiling not retrieved
Sequoia / Ruane CunniffNot retrievedComparison not retrievedFiling not retrieved
Southeastern Asset ManagementNot retrievedComparison not retrievedFiling not retrieved
Tweedy, BrowneNot retrievedComparison not retrievedFiling not retrieved
Yacktman Asset ManagementNot retrievedComparison not retrievedFiling not retrieved

Position size uses shares and filed value from each manager’s 13F. Portfolio weight uses the eligible long-share filing denominator. Changes compare only with the immediately preceding calendar quarter.

Source: Filing source not retrieved · event Jun 30, 2026 · retrieved Nov 12, 2026

Flagship explainer

What Exascale Labs Holdings Inc. insiders reported

We could not retrieve insider activity for this rendering; no zero-activity claim is shown.

Unavailable: Form 4 activity could not be retrieved for this rendering.

Moat Score history

42 logged readings since Jul 18, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale45.2 / 100
0406080100WideNarrowShallowNo moatSep 29, 2026Nov 12, 2026

Tier changesSame-methodology and same-normalizer crossings of the Wide / Narrow / Shallow bars

  1. Not ratedShallow moatSep 29, 2026
  2. Normalizer upgraded unstamped (version unknown)moat-xbrl-normalizer@1.1.0 — readings across versions aren’t comparedJul 26, 2026
  3. Methodology upgraded moat-index@2.0.0moat-index@3.0.0 — readings across versions aren’t comparedJul 23, 2026
  4. Methodology upgraded moat-index@1.2.0moat-index@2.0.0 — readings across versions aren’t comparedJul 20, 2026

Scores are logged append-only and never overwritten — this record cannot be reconstructed retroactively, which is exactly why it’s worth keeping.

Insider activity

Form 4 reports mix P/S market or private transactions with compensation-plan mechanics. Activity casually described as “insider selling” can include compensation mechanics; awards, tax withholding, and option exercises are shown by their exact filed class here, never collapsed into “Bought” or “Sold.”

These are disclosed filing facts and arithmetic aggregates, not a signal or verdict.

The insider-filing service is temporarily unavailable, so no partial or guessed answer is shown for XLAB.

Technology context

#382 of 754 scored Technology companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #380QXL QUANTUM X LABS INC.45.2Shallow moat
  2. #381TTEC TTEC Holdings, Inc.45.2Shallow moat
  3. #383MAX MediaAlpha, Inc.45.1Shallow moat
  4. #384FIVN Five9, Inc.45.0Shallow moat

Compare XLAB with its nearest peers →All Technology companies on the Index →

Common questions about XLAB

Does Exascale Labs Holdings Inc. have an economic moat?
Based on its FY2026 SEC filings, the Moat Index scores Exascale Labs Holdings Inc. (XLAB) 45.2 out of 100 — a Shallow moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 50, pricing power 32, returns on capital not measurable from the filings, balance-sheet safety 55, capital allocation 44.
How has XLAB's Moat Score changed over time?
The record logs 42 readings since Jul 18, 2026; the latest reads 45.2 out of 100 (shallow moat). Tier changes so far: Not rated → Shallow moat on Sep 29, 2026. (Methodology or normalizer upgrades on Jul 20, 2026, Jul 23, 2026, Jul 26, 2026 re-based the score; readings across versions aren't compared.) The history is append-only — readings are only ever added, never rewritten.

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell XLAB. See the disclaimer.